Sihai network

List of 70 drugs for national health insurance negotiation in 2019

Through the latest negotiations, in the new national medical insurance drug catalogue, another 70 drugs have been added to the medical insurance reimbursement, and another 27 drugs have been 'renewed'. The success of the negotiations is mostly new drugs with high clinical value in recent years, involving more than 10 clinical treatments, such as cancer, rare diseases, hepatitis, diabetes, multi drug resistant tuberculosis, rheumatic immunity, cardiovascular and cerebrovascular diseases, digestion and so on. From the point of view of key areas, all 5 essential drugs have been successfully negotiated. 22 anticancer drugs, 7 rare drugs, 14 chronic diseases (including diabetes, hepatitis B, rheumatoid arthritis, etc.) and 4 children have been successfully negotiated. lsquo;& rsquo;